IL-1? enhances inflammatory TH2 differentiation - 03/09/16
Doi : 10.1016/j.jaci.2016.02.033
Stephan M. Caucheteux, PhD a, ∗ 
, Jane Hu-Li, BA a, ∗, Liying Guo, PhD a, Nisan Bhattacharyya, PhD b, Michelle Crank, MD a, c, Michael T. Collins, MD b, William E. Paul, MD a, †
, Jane Hu-Li, BA a, ∗, Liying Guo, PhD a, Nisan Bhattacharyya, PhD b, Michelle Crank, MD a, c, Michael T. Collins, MD b, William E. Paul, MD a, † a Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, and Division of Intramural Research, National Institutes of Health, Bethesda, Md
b National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Md
c Viral Pathogenesis Laboratory, Vaccine Research Center, National Institutes of Health, Bethesda, Md
| This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2016
American Academy of Allergy, Asthma & Immunology. Tous droits réservés.
Vol 138 - N° 3
P. 898 - septembre 2016 Retour au numéro
Article précédent
- Immunologic defects in severe mucocutaneous HSV-2 infections: Response to IFN-? therapy
- Peer Arts, Frank L. van de Veerdonk, Robin van der Lee, Martijn A. Langereis, Christian Gilissen, Wendy A.G. van Zelst-Stams, Martijn A. Huynen, Jos W.M. van der Meer, Frank J. van Kuppeveld, Joris A. Veltman, Bart Jan Kullberg, Alexander Hoischen, Mihai G. Netea
- Migration and allergic diseases in a rural area of a developing country
- Alejandro Rodriguez, Maritza G. Vaca, Martha E. Chico, Laura C. Rodrigues, Mauricio L. Barreto, Philip J. Cooper
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?